SREBF1 and neoplasm: However, one study confirmed that intratumoral Tregs indirectly promote M2-like TAMs by boosting SREBP1-dependent lipid metabolism and then limiting the CD8+ T-produced interferon-gamma (IFNγ), thereby leading to tumor progression and orchestrating tumor-associated immunosuppression [92].